Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002576
UniProt IDP60903
Primary gene name(s)S100A10
Synonym gene name(s)ANX2LG, CAL1L, CLP11
Protein nameProtein S100-A10
Protein functionBecause S100A10 induces the dimerization of ANXA2/p36, it may function as a regulator of protein phosphorylation in that the ANXA2 monomer is the preferred target, in vitro of tyrosine-specific kinase.
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P60903
Gene Ontology
(Biological Process)
Complete annatation
establishment of protein localization to plasma membrane [GO:0090002];
membrane budding [GO:0006900];
membrane raft assembly [GO:0001765];
positive regulation of binding [GO:0051099];
positive regulation of focal adhesion assembly [GO:0051894];
positive regulation of GTPase activity [GO:0043547];
positive regulation of stress fiber assembly [GO:0051496];
positive regulation of substrate adhesion-dependent cell spreading [GO:1900026];
protein heterotetramerization [GO:0051290]
Gene Ontology
(Molecular Function)
Complete annatation
calcium ion binding [GO:0005509];
ion channel binding [GO:0044325];
protein homodimerization activity [GO:0042803]
Gene Ontology
(Cellular Component)
Complete annatation
extracellular exosome [GO:0070062];
extrinsic component of plasma membrane [GO:0019897]
Protein-protein interaction112189
Phylogenetic treeP60903
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-1.547237465693644.91607172803388e-063.25692453120556e-05
AZA vs. DISU-0.04224174525155890.8676156112138840.991211477030548
AZA vs. IL7-0.137861283580650.4742108539100250.999311006273513
AZA vs. SAHA-0.396837699986410.1042556467562720.410112113570993
DISU vs. CD31.492620143521698.1588845830316e-050.00047357345477327
DISU vs. IL7-0.1052510313310130.6787369436283140.913206677311528
DISU vs. SAHA-0.3522736064531480.2287869033287060.606474310802518
DMSO vs. AZA-0.2308788436379640.1685121281765291
DMSO vs. CD31.307624732709216.89032801628464e-050.000323171829281843
DMSO vs. DISU-0.1897423212539140.4380388460032580.882432295026854
DMSO vs. IL70.09977279487977480.5797187262010840.906850405753591
DMSO vs. SAHA-0.1723745355641250.4647550019430940.792417155632127
HIV vs. Mock in Activation-0.1165352129105380.8520502503801540.999983755607037
HIV vs. Mock in Latency0.01602025974157860.9227814640313390.999834320637052
IL7 vs. CD31.416127405089621.63822426781923e-050.000119002189825732
SAHA vs. CD31.127127406235670.001802329932741320.0059187431001115
SAHA vs. IL7-0.2611984657317640.2842717568743690.532047735674725
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.221109 0.110457
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.933 1.099 1.583 1.215 1.149
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1A4P X-ray 2.2Å A/B=2-97.
1BT6 X-ray 2.4Å A/B=2-97.
4DRW X-ray 3.5Å A/B/C/D=1-93.
4FTG X-ray 2.5Å A/B=2-97.
4HRE X-ray 2.7Å E/F/I/J=2-97.
4HRG X-ray 2.0Å A/B=1-93.
4HRH X-ray 3.0Å A/B=1-93.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found